Pharmafile Logo
Pharmafocus logo
Advanced Search

gene editing

Showing 12 posts of 12 posts found.

4972850923_170b36c774

Researchers have tested CRISPR gene editing inside a person’s body for the first time

March 5, 2020
Business Services Editas, crispr, gene editing

Allergan and Editas Medicine have treated their first patient in a clinical trial with CRISPR gene editing. This therapy is …

News

Genetically modified twins may have been altered in a way that improves memory and cognition

February 22, 2019
Medical Communications CCR5, HIV, cognitive enhancement, crispr, gene editing

The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that …

News

Scientist who genetically modified babies faces punishment after acting illegally, Chinese authorities confirm

January 22, 2019
Manufacturing and Production China, He Jiankui, crispr, ethics, gene editing

Chinese state media have confirmed that He Jiankui, the scientist who claimed to have genetically modified babies to prevent them …

News
mosquito-1016254_1280

Researchers eliminate mosquito population through CRISPR gene editing technology

September 27, 2018
Research and Development crispr, gene editing, imperial college london, malaria, mosquitoes

Researchers at Imperial College London have been able to wipe out a population of mosquitoes through ‘gene drive’ technology. The …

News

CRISPR gene editing may frequently cause undetected genetic damage

July 17, 2018
Manufacturing and Production DNA, crispr, gene editing, genetic damage

Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …

News
gene_editing

Gene editing carried out, distances ‘designer baby’ possibility

August 3, 2017
Research and Development biotech, crispr, drugs, gene editing, pharma, pharmaceutical

The news broke last week that scientists in the US had carried out the first gene editing testing in the …

News
dna

US scientists carry out first editing of human embryos

July 28, 2017
Medical Communications, Research and Development biotech, crispr, drugs, gene editing, gene-editing, pharma, pharmaceutical

In what will be regarded as a watershed moment, scientists working at Oregon Health and Science University have used CRISPR …

News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017
Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …

News
shutterstock_123182704

Horizon and Fulcrum Therapeutics form CRISPR collaboration

September 6, 2016
Manufacturing and Production, Research and Development Horizon Discovery, crispr, fulcrum, fulcrum therapeutics, gene editing, horizon, rare diseases

Horizon Discovery has announced that it has entered into a partnership with Fulcrum Therapeutics to utilise Horizon’s CRISPR-based screening platform …

News
casebia

Bayer’s CRISPR venture opens for business in biotech hub

August 23, 2016
Manufacturing and Production, Research and Development Bayer, casebia, crispr, gene editing, gene-editing

Bayer and CRISPR Therapeutics have joined together to launch Casebia Therapeutics and have chosen Cambridge, Massachusetts, as its base to …

News
lab

Federal panel to review proposal for first human CRISPR test

June 20, 2016
Research and Development, Sales and Marketing crispr, gene editing, human testing, oncology

A US Federal safety board is set to review a proposal for the first human use of the gene editing …

News
regeneron

Regeneron agrees six-year $75 million upfront licencing deal with Intellia for gene technology

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing IPO, Intellia Therapeutics, Licencing, Regeneron Pharmaceuticals, crispr, deal, gene editing, genetics

Regeneron Pharmaceuticals Inc (Nasdaq: REGN) on Tuesday said it has signed a six-year licencing deal with biotech firm Intellia Therapeutics …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024